s6y
Company name or ticker
Search
Compass Therapeutics, Inc.
SC 14F1
Statement regarding change in majority of directors pursuant to Rule 14f-1
Filed
Wednesday, May 27, 2020
Accession number
0001213900-20-013547
Documents
SCHEDULE 14F-1
SC 14F1
On sec.gov
Filing index
All files
Complete submission text
SGML header